BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32968646)

  • 1. COVID-19 pandemic and stent thrombosis in a post percutaneous coronary intervention patient-a case report highlighting the selection of P2Y12 inhibitor.
    Choudhary R; Kaushik A; Sharma JB
    Cardiovasc Diagn Ther; 2020 Aug; 10(4):898-901. PubMed ID: 32968646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis.
    Pallangyo P; Bhalia SV; Komba M; Mkojera ZS; Mayala HA; Kifai E; Kisenge PR
    Egypt Heart J; 2023 Oct; 75(1):85. PubMed ID: 37823944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S; Richartz BM; Brilmayer M;
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Two-Vessel Subacute Stent Thrombosis Caused by Clopidogrel Resistance from CYP2C19 Polymorphism.
    Afzal A; Patel B; Patel N; Sattur S; Patel V
    Case Rep Med; 2016; 2016():2312078. PubMed ID: 27555873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
    Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
    Godschalk TC; Byrne RA; Adriaenssens T; Malik N; Feldman LJ; Guagliumi G; Alfonso F; Neumann FJ; Trenk D; Joner M; Schulz C; Steg PG; Goodall AH; Wojdyla R; Dudek D; Wykrzykowska JJ; Hlinomaz O; Zaman AG; Curzen N; Dens J; Sinnaeve P; Desmet W; Gershlick AH; Kastrati A; Massberg S; Ten Berg JM;
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2548-2556. PubMed ID: 29268884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential development of cardiac tamponade and subacute stent thrombosis after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: A case report.
    Kim SS; Jeong MH; Sim DS; Park KH; Hong YJ; Kim JH; Ahn YK; Kang JC
    J Cardiol Cases; 2010 Apr; 1(2):e75-e79. PubMed ID: 30615770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent thrombosis after primary percutaneous coronary intervention in comatose survivors of out-of-hospital cardiac arrest: Are the new P2Y12 inhibitors really more effective than clopidogrel?
    Gouffran G; Rosencher J; Bougouin W; Jakamy R; Joffre J; Lamhaut L; Dumas F; Cariou A; Varenne O
    Resuscitation; 2016 Jan; 98():73-8. PubMed ID: 26610376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes.
    Joshi RR; Hossain R; Morton AC; Ecob R; Judge HM; Wales C; Walker JV; Karunakaran A; Storey RF
    Platelets; 2014; 25(6):416-22. PubMed ID: 24111601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.
    Dayoub EJ; Seigerman M; Tuteja S; Kobayashi T; Kolansky DM; Giri J; Groeneveld PW
    JAMA Intern Med; 2018 Jul; 178(7):943-950. PubMed ID: 29799992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.
    Lattuca B; Belardi D; Demattei C; Schmutz L; Cornillet L; Ledermann B; Macia JC; Iemmi A; Gervasoni R; Roubille F; Cung TT; Robert P; Messner-Pellenc P; Leclercq F; Cayla G
    J Invasive Cardiol; 2018 Sep; 30(9):348-354. PubMed ID: 30012889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials.
    Garg A; Rout A; Sharma A; Sargsyan D; Beavers T; Tantry U; Gurbel P; Rao SV; Kostis JB; Cohen M
    Prog Cardiovasc Dis; 2020; 63(3):243-248. PubMed ID: 32247786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple Coronary Artery Thrombosis Presenting as Acute Anterior ST-Segment Elevation Myocardial Infarction.
    Ermis E; Kahraman S; Ucar H; Ozyılmaz SO; Allahverdiyev S
    Int J Angiol; 2018 Dec; 27(4):223-226. PubMed ID: 30410294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management after coronary stent implantation: a review.
    Brilakis ES; Patel VG; Banerjee S
    JAMA; 2013 Jul; 310(2):189-98. PubMed ID: 23839753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors.
    Ristorto J; Messas N; Marchandot B; Kibler M; Hess S; Meyer N; Schaeffer M; Tuzin N; Ohlmann P; Jesel L; Morel O
    J Atheroscler Thromb; 2018 Aug; 25(8):674-689. PubMed ID: 29415954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Subacute Stent Thrombosis.
    Mijares-Rojas IA; Martinez EF; Leonor Lopez GL; De Marchena E; Alfonso CE
    Cureus; 2023 Apr; 15(4):e37725. PubMed ID: 37206507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late stent thrombosis in a patient with CYP2C19*3/*17 genotype and clopidogrel high on-treatment platelet reactivity.
    Tan SSN; Koh KT; Tiong LL; Ong TK; Fong AYY
    Pharmacogenomics; 2018 Oct; 19(15):1151-1157. PubMed ID: 30191759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status of Antiplatelet Therapy in Acute Coronary Syndrome.
    Dash D
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):40-9. PubMed ID: 26245659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention: individual efficacy and hemorrhagic safety of P2Y12 blockers of ticagrelor and clopidogrel in actual clinical practice].
    Korotaeva ES; Koroleva LY; Kovaleva GV; Kuzmenko EA; Nosov VP
    Kardiologiia; 2019 Jun; 59(5S):27-36. PubMed ID: 31221073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.
    Rafique AM; Nayyar P; Wang TY; Mehran R; Baber U; Berger PB; Tobis J; Currier J; Dave RH; Henry TD
    JACC Cardiovasc Interv; 2016 May; 9(10):1036-46. PubMed ID: 27198684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.